肿瘤相关成纤维细胞的来源和分子机制

Abstract

Abstract: Carcinoma-associated fibroblasts (CAFs) have not only been showed to play a crucial role in growth,progression and metastasis of tumors but also in the deposition of extracellular matrix (ECM).The normal fibroblasts,epithelial cells,endothelial cells and mesenchymal stem cells (MSCs) are recognized as the main source of CAFs.This paper aims to review the recent advances at the origin of the CAFs and its molecular mechanisms and possibility as potential therapeutic targets.

Key words: Carcinoma-associated fibroblasts, Normal fibroblasts, Epithelial-to-mesenchymal transition, Endothelial to mesenchymal transition, Mesenchymal stem cell, Cancer

CLC Number:

R730.2

ZHANG Hui, FAN Yue-zu, WANG Jin-si, LIN Meng-bo. The origin of carcinoma-associated fibroblasts and its molecular mechanisms[J]. Surgical Research and New Technique, 2014, 3(1): 1-7.

References

[1] Balkwill F,Mantovani A.Inflammation and cancer:back to Virchow?[J].Lancet,2001,357(9255):539-545.
[2] Wever OD,Mareel M.Role of tissue stroma in cancer cell invasion[J].J Pathol,2003,200(4):429-447.
[3] Xouri G,Christian S.Origin and function of tumor stroma fibroblasts[J].Semin Cell Dev Biol,2010,21(1):40-46.
[4] Mueller MM,Fusenig NE.Friends or foes-Bipolar effects of the tumour stroma in cancer[J].Nature Reviews Cancer,2004,4(11):839-849.
[5] Sugimoto H,Mundel TM,Kieran MW,et al.Identification of fibroblast heterogeneity in the tumor microenvironment[J].Cancer Biol Therapy,2006,5(12):1640-1646.
[6] Park JE,Lenter MC,Zimmermann RN,et al.Fibroblast activation protein,a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts[J].J Biol Chem1999,274(51):36505-36512.
[7] Ostman A,Augsten M.Cancer-associated fibroblasts and tumor growth-bystanders turning into key players[J].Curr Opin Genet Dev,2009,19(1):67-73.
[8] Tyan SW,Kuo WH,Huang CK,et al.Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesis[J].PLoS One,2011,6(1):5313.
[9] Liao CP,Adisetiyo H,Liang M,et al.:Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells[J].Cancer Res,2010,70(18):7294-7303.
[10] Zhi K,Shen X,Zhang H,et al.Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers[J].J Exp Clin Cancer Res,2010,29(8):66.
[11] Shinagawa K,Kitadai Y,Tanaka M,et al.Mesenchymal stem cells enhance growth and metastasis of colon cancer[J].Int J Cancer 2010,127(10):2323-2333.
[12] Zhang YA,Tang HJ,Cai J,et al.Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis,lymphangiogenesis and tumor cell invasion[J].Cancer Lett,2011,303(1):47-55.
[13] Angeli F KG,Chen MC,Kumar S,et al.Role of stromal fibroblasts in cancer:promoting or impeding?[J].Tumor Biol ,2009,30(3):109-120.
[14] Zeisberg RKM.Fibroblasts in cancer.Nature Reviews Cancer,2006,6(5):392-401.
[15] Anderberg C,Li H,Fredriksson L,et al.Paracrine signaling by platelet-derived growth factor-C promotes tumor growth by recruitment of cancer-associated fibroblasts[J].Cancer Res,2009,69(1):69-378.
[16] Augsten M,Hgglf C,Pea C,et al.A digest on the role of the tumor microenvironment in gastrointestinal Cancers[J].Cancer Microenvironment,2010,3(1):167-176.
[17] Fukino K,Shen L,Patocs A,et al.Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma[J].JAMA,2007,297(19):2103-2111.
[18] Frank Weber,Yaomin Xu,Li Zhang.Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma[J].JAMA,2007,297(2):187-195.
[19] Qiu W,Hu M,Sridhar A,et al.No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas[J].Nature Genetics,2008,40(5):650-655.
[20] Walter K,Omura N,Hong SM,et al.Brief report:pancreatic cancer associated fibroblasts display normal allelotypes[J].Cancer Biol Therapy,2008,7(6):882-888.
[21] Allen M,Louise Jones J.Jekyll and Hyde:the role of the microenvironment on the progression of cancer[J].J Pathol,2011,223(2):163-177.
[22] Hinshelwood RA,Huschtscha LI,Melki J,et al.Concordant epigenetic silencing of transforming growth factor-signaling pathway genes occurs early in breast carcinogenesis[J].Cancer Res,2007,67(24):11517-11527.
[23] Tsujino T,Seshimo I,Yamamoto H,et al.Stromal myofibroblasts predict disease recurrence for colorectal cancer[J].Clin Cancer Res,2007,13(7):2082-2090.
[24] Paulsson J,Sjblom T,Micke P,et al.Prognostic significance of stromal platelet-derived growth factor β-receptor expression in human breast cancer[J].Am J Pathol,2009,175(1):334-341.
[25] Kurose K,Gilley K,Matsumoto S,et al.Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas[J].Nature Genetics,2002,32(3):355 - 357
[26] Weber F,Fukino K,Sawada T,et al.Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors[J].Br J Cancer,2005,92(10):1922-1926.
[27] Hu M,Yao J,Cai L,et al.Distinct epigenetic changes in the stromal cells of breast cancers[J].Nature Genetics,2005,37(8):899-905.
[28] Barcellos-Hoff MH,Ravani SA.Irradiated Mammary Gland Stroma Promotes the Expression of Tumorigenic Potential by Unirradiated Epithelial Cells[J].Cancer Res,2000,60(5):1254-1260.
[29] Ohuchida K,Mizumoto K,Murakami M,etal.Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions[J].Cancer Res,2004,64(9):3215-3222.
[30] Mercier I,Casimiro MC,Wang C,et al.Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation:Implications for the response to hormonal therapy[J].Cancer Biol Ther,2008,7(8):1212-1225.
[31] Bauer M,Su G,Casper C,et al.Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast[J].Oncogene,2010,29(12):1732-1740.
[32] Patocs A,Zhang L,Xu YM,et al.Breast-Cancer Stromal Cells with TP53 Mutations and Nodal Metastases[J].N Engl J Med,2007,357(25):2543-2551.
[33] Polyak K,Haviv I,Campbell IG.Co-evolution of tumor cells and their microenvironment[J].Trends in Genetics,2009,25(1):30-38.
[34] Campbell I,Qiu W,Haviv I.Genetic changes in tumour microenvironments[J].J Pathol,2011,223(4):450-458.
[35] Casey TM,Eneman J,Crocker A,et al.Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-β1) increase invasion rate of tumor cells:a population study[J].Breast Cancer Res Treat,2007,110(1):39-49.
[36] Haubeiss S,Schmid JO,Muerdter TE,et al.Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts[J].Mo Cancer,2010,27(9):168.
[37] Dudás J,Bitsche M,Schartinger V,et al.Fibroblasts produce brain-derived neurotrophic factor and induce mesenchymal transition of oral tumor cells[J].Oral Oncol,2011,47(2):98-103.
[38] Huber MA,Kraut N,Beug H.Molecular requirements for epithelial-mesenchymal transition during tumor progression[J].Cur Opin Cell Biol,2005,17(5):548-558.
[39] Polyak K,Weinberg RA.Transitions between epithelial and mesenchymal states:acquisition of malignant and stem cell traits[J].Nature Reviews Cancer,2009,9(4):265-273.
[40] Hazan RB,Qiao R,Keren R,et al.Cadherin Switch in Tumor Progression[J].Ann N Y Acad Sci,2004,Apr,1014:155-163.
[41] Medici D,Hay ED,Olsen BR.Snail and Slug promote epithelial-mesenchymal transition through β-catenin-T-cell factor-4-dependent expression of transforming growth factor-β3[J].Mol Biol Cell,2008,19(11):4875-4887.
[42] Kalluri R,Weinberg RA.The basics of epithelial-mesenchymal transition[J].J Clin Invest,2009,119(6):1420-1428.
[43] Peinado H,Olmeda D,Cano A.Snail,Zeb and bHLH factors in tumour progression:an alliance against the epithelial phenotype? [J].Nature Reviews Cancer,2007,7(6):415-428.
[44] Acloque H,Thiery JP,Nieto MA.The physiology and pathology of the EMT.Meeting on the Epithelial-Mesenchymal Transition[J].EMBO reports,2008,9(4):322-326.
[45] Wyatt L,Wadham C,Crocker LA,et al.The protein tyrosine phosphatase Pez regulates TGFβ,epithelial-mesenchymal transition,and organ development[J].J Cell Biol,2007,178(7):1223-1235.
[46] Waerner T,Alacakaptan M,Tamir I,et al.ILEI:A cytokine essential for EMT,tumor formation,and late events in metastasis in epithelial cells[J].Cancer Cell,2006,10(3):227-239.
[47] Thuault S,Valcourt U,Petersen M,et al.Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition[J].J Cell Biol,2006,174(2):175-183.
[48] Laberge RM,Awad P,Campisi J,et al.Epithelial-mesenchymal transition induced by senescent fibroblasts[J].Cancer Microenviron,2012,5(1):39-44.
[49] Moustakas A,Heldin C-H.Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression[J].Cancer Sci,2007,98(10):1512-1520.
[50] Massagué J.TGFβ in Cancer[J].Cell,2008,134(2):215-230.
[51] Mercado-Pimentel ME,Runyan RB.Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart[J].Cells Tissues Organs,2007,185(1-3):146-156.
[52] Bailey JM,Singh PK,Hollingsworth MA.Cancer metastasis facilitated by developmental pathways:Sonic hedgehog,Notch,and bone morphogenic proteins[J].J Cell Biochem,2007,102(4):829-839.
[53] Wang Z,Banerjee S,Li Y,et al.Down-regulation of Notch-1 Inhibits Invasion by Inactivation of Nuclear Factor-κB,Vascular Endothelial Growth Factor,and Matrix Metalloproteinase-9 in Pancreatic Cancer Cells[J].Cancer Res,2006,66(5):2778-2784.
[54] Zhang C,Carl TF,Trudeau ED,et al.An NF-κB and Slug regulatory loop active in early vertebrate mesoderm[J].PLoS One,2006,27(1):e106.
[55] Julien S,Puig I,Caretti E,et al.Activation of NF-B by Akt upregulates Snail expression and induces epithelium mesenchyme transition[J].Oncogene,2007,26(53):7445-7456.
[56] Suzuki H,Watkins DN,Jair K-W,et al.Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer[J].Nature Genetics,2004,36(4):417-422.
[57] Zhang W,Glckner SC,Guo M,et al.Epigenetic inactivation of the canonical Wnt antagonist SRY-Box containing gene 17 in colorectal cancer[J].Cancer Res,2008,68(8):2764-2772.
[58] Aguilera O,Fraga MF,Ballestar E,et al.Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer[J].Oncogene,2006,25(29):4116-4121.
[59] Hugo H,Ackland ML,Blick T,et al.Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression[J].J Cell Physiol,2007,213(2):374-383.
[60] Cannito S,Novo E,Compagnone A,et al.Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells[J].Carcinogenesis,2008,29(12):2267-2278.
[61] Vooijs MA,Gort EH,Groot AJ,et al.Hypoxic regulation of metastasis via hypoxia-inducible factors[J].Cur Mol Med,2008,8(1):60-67.
[62] Dunbier A,Guilford P.Hereditary diffuse gastric cancer[J].Advances Cancer Res,2001,83(1):55-65.
[63] Bloushtain-Qimron N,Yao J,Snyder EL,et al.Cell type-specific DNA methylation patterns in the human breast[J].Nat Acad Sci USA,2008,105(37):14076-14081.
[64] Thiery JP,Acloque H,Huang RY,et al.Epithelial-mesenchymal transitions in development and disease[J].Cell,2009,139(5):871-890.
[65] Zeisberg EM,Potenta S,Xie L,et al.Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts[J].Cancer Res,2007,67(21):10123-10128.
[66] Potenta S,Zeisberg E,Kalluri R.The role of endothelial-to-mesenchymal transition in cancer progression[J].Br J Cancer,2008,99(9):1375-1379.
[67] Timmerman LA,Grego-Bessa J,Raya A,et al.Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation[J].Genes Dev,2004,18(1):99-115.
[68] Barry FP,Murphy JM.Mesenchymal stem cells:clinical applications and biological characterization[J].Int J Biochem Cell Biol,2004,36(4):568-584.
[69] Studeny M,Marini FC,Dembinski JL,et al.Mesenchymal stem cells:Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents[J].J Nat Cancer Inst,2004,96(21):1593-1603.
[70] Direkze NC.Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts[J].Cancer Res,2004,64(23):8492-8495.
[71] Ogawa M,LaRue AC,Drake CJ.Hematopoietic origin of fibroblasts/myofibroblasts:Its pathophysiologic implications[J].Blood,2006,108(9):2893-2896.
[72] Mishra PJ,Humeniuk R,Medina DJ,et al.Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells[J].Cancer Res,2008,68(11):4331-4339.
[73] Jeon ES,Lee IH,Heo SC,et al.Mesenchymal stem cells stimulate angiogenesis in a murine xenograft model of A549 human adenocarcinoma through an LPA1 receptor-dependent mechanism[J].Biochim Biophys Acta-Mol Cell Biol Lipids,2010,1801(11):1205-1213.

The origin of carcinoma-associated fibroblasts and its molecular mechanisms

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	YAN Guoxin, REN Hang. Clinical comparison of low-temperature plasma radiofrequency operation and high-frequency electrosurgical resection in treatment of early tongue cancer [J]. Surgical Research and New Technique, 2021, 10(1): 42-44.
[2]	WANG Xiaona, LIN Xulin, LIN Gengbin, HUANG Junping. Effects of different anesthesia methods on postoperative outcome of patients undergoing laparoscopic radical resection of colorectal cancer [J]. Surgical Research and New Technique, 2021, 10(1): 57-60.
[3]	WANG Hui, WANG Fangtao, FAN Yuezu. Research progress on anti-lymphangiogenesis in colorectal cancer [J]. Surgical Research and New Technique, 2021, 10(1): 64-67.
[4]	JIN Hailong, WU Biao, ZHANG Yi. Influences of different local regional recurrence on prognosis of breast cancer patients after surgery [J]. Surgical Research and New Technique, 2020, 9(3): 149-153.
[5]	WEI Yuhua, SHI Baomin. Advances on treatment of liver diseases using mesenchymal stem cells [J]. Surgical Research and New Technique, 2020, 9(2): 105-109.
[6]	LIU Congcong, SHI Baomin. Factors influencing complete response rate of liver cancer after percutaneous radiofrequency ablation [J]. Surgical Research and New Technique, 2020, 9(1): 1-5.
[7]	WU Songling, ZHANG Meize, LIU Jiahui, ZHAN Qiaohui. Factors of non-sentinel lymph node metastasis in 98 early breast cancer patients [J]. Surgical Research and New Technique, 2020, 9(1): 6-9.
[8]	YANG Xiuchun, WANG Pan. Observation of short-term effect of laparoscopic radical operation for colorectal cancer [J]. Surgical Research and New Technique, 2020, 9(1): 14-16.
[9]	PAN Jianhai, LI Zhongmin, HUA Jiancan. Observation of effect of intraperitoneal perfusion during laparoscopic radical gastrectomy on advanced gastric cancer [J]. Surgical Research and New Technique, 2020, 9(1): 17-19.
[10]	CHEN Kai, WU Zuguang, YAO Shiwei, DENG Xueyong, LIU Zhanying. Evaluation of effect of non-dissected Roux-en-Y anatomosis on digestive tract reconstruction after laparoscopic resection for distal gastric cancer [J]. Surgical Research and New Technique, 2020, 9(1): 20-21.
[11]	WANG Yongliang, CHAI Hui, ZHAO Hongqing, WANG Huaijin, CHU Ruijun, GUO Siliang, ZHAI Yaojun. Effects of tamoxifen and anastrazole endocrine therapies for breast canceron bone metabolism [J]. Surgical Research and New Technique, 2019, 8(4): 262-264.
[12]	CHEN Ye, ZHENG Jiagang. New endoscopic techniques for diagnoses of early gastrointestinal cancers [J]. Surgical Research and New Technique, 2019, 8(4): 278-283.
[13]	ZENG Lihong. Effects of targeted nursing based on active pain assessment on pain, sleep, and recovery of patients with hepatocellular carcinoma after operation [J]. Surgical Research and New Technique, 2019, 8(4): 288-290.
[14]	CHEN Manqing, WU Chunshan, SHE Danyu, FANG Zhichao, ZENG Canyi, XU Lishan. Application of axillary ultrasound combined with methylene blue in sentinel lymph node biopsy of breast cancer [J]. Surgical Research and New Technique, 2019, 8(3): 163-166.
[15]	CHEN Jinbao, QIU Yanyan, XU Ke, HE Xue, WU Honglei, ZENG Yijun, YIN Peihao. Meta analysis of efficacy and safety of FOLFOX regimen and XELOX regimen in patients with advanced colon cancer [J]. Surgical Research and New Technique, 2019, 8(2): 73-83.